MRC1 and glioma: The glioma TAMs in our dataset did not follow a binary split into the classic “M1” proinflammatory and “M2” immunosuppressive phenotypes.26 Instead, we observed simultaneous coexpression of M1 markers (MHC-II) and M2 markers (PD-L1, CD206) in every permutation.